Publication | Closed Access
Clinical trial: the glucagon‐like peptide‐1 analogue ROSE‐010 for management of acute pain in patients with irritable bowel syndrome: a randomized, placebo‐controlled, double‐blind study
89
Citations
16
References
2008
Year
ROSE-010 was well tolerated and provided fast and effective relief of acute pain attacks on demand in IBS patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1